Get started
BIOCRYST PHARMACEUTICALS INCBIOCRYST PHARMACEUTICALS INCBIOCRYST PHARMACEUTICALS INC

BIOCRYST PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

BO1 chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪1.19 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.99EUR
Net income (FY)
‪−205.25 M‬EUR
Revenue (FY)
‪300.26 M‬EUR
Shares float
‪198.14 M‬
Beta (1Y)
1.22

About BioCryst Pharmaceuticals, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Jon P. Stonehouse
Website
biocryst.com
Headquarters
Durham
Employees (FY)
536
Founded
1986
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BO1 is 5.89 EUR — it has increased by 4.36% in the past 24 hours. Watch BIOCRYST PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange BIOCRYST PHARMACEUTICALS INC stocks are traded under the ticker BO1.
BO1 stock has risen by 13.44% compared to the previous week, the month change is a 37.73% rise, over the last year BIOCRYST PHARMACEUTICALS INC has showed a 24.29% decrease.
We've gathered analysts' opinions on BIOCRYST PHARMACEUTICALS INC future price: according to them, BO1 price has a max estimate of 27.86 EUR and a min estimate of 5.57 EUR. Watch BO1 chart and read a more detailed BIOCRYST PHARMACEUTICALS INC stock forecast: see what analysts think of BIOCRYST PHARMACEUTICALS INC and suggest that you do with its stocks.
BO1 reached its all-time high on Feb 16, 2022 with the price of 17.59 EUR, and its all-time low was 1.32 EUR and was reached on Nov 14, 2019. View more price dynamics on BO1 chart.
See other stocks reaching their highest and lowest prices.
BO1 stock is 5.59% volatile and has beta coefficient of 1.22. Track BIOCRYST PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is BIOCRYST PHARMACEUTICALS INC there?
Today BIOCRYST PHARMACEUTICALS INC has the market capitalization of ‪1.17 B‬, it has increased by 3.82% over the last week.
Yes, you can track BIOCRYST PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
BIOCRYST PHARMACEUTICALS INC is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
BO1 earnings for the last quarter are −0.16 EUR per share, whereas the estimation was −0.19 EUR resulting in a 18.80% surprise. The estimated earnings for the next quarter are −0.16 EUR per share. See more details about BIOCRYST PHARMACEUTICALS INC earnings.
BIOCRYST PHARMACEUTICALS INC revenue for the last quarter amounts to ‪85.97 M‬ EUR despite the estimated figure of ‪79.35 M‬ EUR. In the next quarter revenue is expected to reach ‪90.49 M‬ EUR.
BO1 net income for the last quarter is ‪−32.79 M‬ EUR, while the quarter before that showed ‪−55.93 M‬ EUR of net income which accounts for 41.37% change. Track more BIOCRYST PHARMACEUTICALS INC financial stats to get the full picture.
No, BO1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 21, 2024, the company has 536.00 employees. See our rating of the largest employees — is BIOCRYST PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOCRYST PHARMACEUTICALS INC EBITDA is ‪−81.77 M‬ EUR, and current EBITDA margin is −30.79%. See more stats in BIOCRYST PHARMACEUTICALS INC financial statements.
Like other stocks, BO1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCRYST PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCRYST PHARMACEUTICALS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCRYST PHARMACEUTICALS INC stock shows the sell signal. See more of BIOCRYST PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.